MedTrace Logo

Treatment of Atrophic Acne Scars With Platelet-Rich Plasma and Skin Needling

NCT02798016 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-01-03

No results posted yet for this study

Summary

Investigators will collect blood specimens from the participating patients and then blood samples will be centrifuged in order to collect platelet-rich plasma which is going to be injected in the atrophic acne scars. A split-face design is going to used in this randomized controlled trial. In the control side of the face, micro-needling to the skin will occur using a specific tool (Dermapen).

Conditions

  • Atrophic Acne Scars

Interventions

PROCEDURE

Platelet-Rich Plasma

This Platelet-Rich Plasma will be taken from each patient and is going to be used in the treatment of atrophic acne scars

PROCEDURE

Micro-needling

Micro-needling will be applied on the acne scars in one side of the face.

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Faiez Al-Deghlaoui, MD MSc PhD · Associate Professor of Dermatology and Veneology, Medical School, University of Damascus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-06-23
Completion
2017-10-20

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02798016 on ClinicalTrials.gov